Crossmark

Immunoinformatic-based drug design utilizing hesperetin to target CISD2 activation for liver aging in humans

Published Online: 2024-08-28

Published Print: 2024-11

Authors

Baig, Saad Ilyas

Naseer, Maria

Munir, Abdur-Rehman

Ali, Yasir

Razzaq, Muhammad Asif
License Information

Text and Data Mining valid from 2024-08-28

Version of Record valid from 2024-08-28
More Information

Article History

Received: 23 May 2024

Accepted: 10 August 2024

First Online: 28 August 2024

Declarations

:

: The authors declare no competing interests.

Document is current